*Some Market data delayed by 15 mins.

Recursion Pharmaceuticals, Inc. Class A Common Stock

Symbol: RXRX (NASDAQ)
4.84 ▼ (-1.43%) -0.070

Company Description:
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Key Stats
  • Today's Open: $4.85
  • Today's High: $4.962
  • Today's Low: $4.735
  • Today's Volume: 28.88M
  • Yesterday Close: $4.91
  • Yesterday High: $5
  • Yesterday Low: $4.7
  • Yesterday Volume: 41.00M
  • Last Min Volume: 5
  • Last Min High: $4.84
  • Last Min Low: $4.84
  • Last Min VWAP: $4.84
Company Profile
  • Name: Recursion Pharmaceuticals, Inc. Class A Common Stock
  • Website: https://www.recursion.com
  • Listed Date: 2021-04-16
  • Location: SALT LAKE CITY, UT
  • Market Status: Active
  • CIK Number: 0001601830
  • SIC Code: 2836
  • SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Market Cap: $2.14B
  • Round Lot: 100
  • Outstanding Shares: 436.55M
  • Asset Type: CS
RECENT FILINGS FOR RXRX
Filing Date Filing Type Format
2025-09-26 4 View
2025-09-25 144 View
2025-09-17 4 View
2025-09-12 4 View
2025-09-10 144 View
2025-08-29 8-K/A View
2025-08-29 424B7 View
2025-08-28 4 View
2025-08-26 144 View
2025-08-19 4 View
2025-08-19 4 View
2025-08-19 4 View
2025-08-18 144 View
2025-08-13 4 View
2025-08-11 144 View
2025-08-05 10-Q View
2025-08-05 8-K View
2025-07-08 8-K View
2025-07-08 424B7 View
2025-07-03 4 View
Latest News on RXRX

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.